| 12508265 |
Methods and compositions for reducing radiation induced toxicity |
Brian D. Frenzel, Philip Liaw |
2025-12-30 |
|
| 12486255 |
Modulators of RAS GTPase |
Annie L. Lennek, Stephen D. Yanofsky, Brian D. Frenzel, Solomon Ungashe, Philip Liaw |
2025-12-02 |
|
| 12419893 |
Methods and compositions for maximizing the prevention and/or reduction of various maladies and drug side-effects using uridine |
Brian D. Frenzel, Philip Liaw |
2025-09-23 |
|
| 12194043 |
Uridine phosphorylase inhibitors to treat or prevent pulmonary disease |
Philip Liaw, Brian D. Frenzel |
2025-01-14 |
|
| 12109222 |
Methods and compositions for treating mucositis |
Brian D. Frenzel, Philip Liaw |
2024-10-08 |
|
| 11945803 |
Modulators of RAS GTPase |
Annie L. Lennek, Stephen D. Yanofsky, Brian D. Frenzel, Solomon Ungashe, Philip Liaw |
2024-04-02 |
|
| 11446303 |
Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions |
Heshan Peiris, Philip Liaw, Brian D. Frenzel |
2022-09-20 |
|
| 11390626 |
Pyrazolopyrimidine modulators of RAS GTPase |
Solomon Ungashe, Stephen D. Yanofsky, Philip Liaw, Annie L. Lennek |
2022-07-19 |
|
| RE48253 |
Methotrexate adjuvants to reduce toxicity and methods for using the same |
Brian D. Frenzel, Travis Karg |
2020-10-13 |
|
| 10660318 |
Non-mammalian RAS transgenic animal model |
Travis Karg, Steve Yanofsky |
2020-05-26 |
|
| 9468613 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same |
Brian D. Frenzel |
2016-10-18 |
|
| 9382287 |
Methotrexate adjuvants to reduce toxicity and methods for using the same |
Brian D. Frenzel, Travis Karg |
2016-07-05 |
|
| 9274129 |
Methods and reagents for detecting bioactive lipids |
Roger A. Sabbadini, Genevieve Hansen |
2016-03-01 |
$82,000 |
| 9217749 |
Immune-derived moieties reactive against lysophosphatidic acid |
Roger A. Sabbadini, Genevieve Hansen |
2015-12-22 |
$192,000 |
| 9181331 |
Pharmaceutical compositions for binding sphingosine-1-phosphate |
Roger A. Sabbadini, Scott R. Pancoast, Genevieve Hansen, Marina Yu SAFONOV |
2015-11-10 |
$171,000 |
| 9163091 |
Compositions and methods for binding lysophosphatidic acid |
Roger A. Sabbadini, Genevieve Hansen, James Stephen SWANEY, Rosalia MATTEO, Gordon MILLS +1 more |
2015-10-20 |
$170,000 |
| 9061038 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same |
Brian D. Frenzel |
2015-06-23 |
|
| 8853227 |
Methotrexate adjuvants to reduce toxicity and methods for using the same |
Brian D. Frenzel, Travis Karg |
2014-10-07 |
|
| 8796429 |
Bioactive lipid derivatives, and methods of making and using same |
Roger A. Sabbadini, Genevieve Hansen |
2014-08-05 |
$595,000 |
| 8614103 |
Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions |
Roger A. Sabbadini, Glenn L. Stoller |
2013-12-24 |
$611,000 |
| 8604172 |
Humanized antibody compositions and methods for binding lysophosphatidic acid |
Roger A. Sabbadini, Genevieve Hansen, Steven Jones, David G. Williams |
2013-12-10 |
$651,000 |
| 8444970 |
Compositions and methods for treating ocular diseases and conditions |
Roger A. Sabbadini, Glenn L. Stoller |
2013-05-21 |
$748,000 |
| 8361465 |
Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents |
Roger A. Sabbadini |
2013-01-29 |
$865,000 |
| 8227517 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same |
Brian D. Frenzel |
2012-07-24 |
|
| 8222373 |
Humanized antibodies and compositions for binding sphingosine-1-phosphate |
Roger A. Sabbadini, Genevieve Hansen, Steven Jones, David G. Williams |
2012-07-17 |
|